MedTrace Logo

Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis

NCT04846374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-05-11

No results posted yet for this study

Summary

Purpose: To describe a novel configuration of venous access for the performance of intermittent apheresis.

Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port.

Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.

Conditions

  • Apheresis

Interventions

DEVICE

PowerPort

The study will compare pheresis sessions with the old system versus pheresis sessions with one of two new configurations.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Peter Bream, MD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-26
Primary Completion
2023-04-14
Completion
2023-04-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04846374 on ClinicalTrials.gov